Aim: To evaluate the therapeutic trajectory of intra-articular injections of hyaluronic acid at high concentration (2%) performed at 4-month intervals.Methods: Subjects with knee osteoarthritis received, after a weekly injection of 32 mg/2 mL hyaluronic acid for 3 weeks, a single injection of 50 mg/2.5 mL hyaluronic acid (not cross-linked, molecular weight 8001200 kDa) at 4-month interval (4, 8 and 12 months). Clinical assessment (visual analogic scale [VAS] for pain at rest and during activities, Lequesne Index [LI], Knee Injury and Osteoarthritis Outcome Score (KOOS), and monthly non-steroidal anti-inflammatory drug consumption) was performed at baseline, and after 1, 4, 6, 8, 12 and 14 months.Results: In the 15 knees treated, pain decreased (baseline vs. 14 months: VAS at rest, 3.7 +/- 1.7 vs. 1 +/- 0.7 [P < 0.000]; VAS activities, 6.2 +/- 1.7 vs. 2.6 +/- 1.3 [P < 0.000]) and function improved (baseline vs. 14 months: KOOS, 51.9 +/- 15.3 vs. 70.2 +/- 13.7 [P < 0.000]; LI, 10 +/- 3.8 vs. 5.4 +/- 2.4 [P < 0.000]) significantly.Conclusions: This schedule provides persistent positive results in terms of reduced pain and improved function, optimizing the protective properties of the hyaluronic acid used.
Hyaluronic acid in knee osteoarthritis: preliminary results using a four months administration schedule
Pantalone, Andrea;
2017-01-01
Abstract
Aim: To evaluate the therapeutic trajectory of intra-articular injections of hyaluronic acid at high concentration (2%) performed at 4-month intervals.Methods: Subjects with knee osteoarthritis received, after a weekly injection of 32 mg/2 mL hyaluronic acid for 3 weeks, a single injection of 50 mg/2.5 mL hyaluronic acid (not cross-linked, molecular weight 8001200 kDa) at 4-month interval (4, 8 and 12 months). Clinical assessment (visual analogic scale [VAS] for pain at rest and during activities, Lequesne Index [LI], Knee Injury and Osteoarthritis Outcome Score (KOOS), and monthly non-steroidal anti-inflammatory drug consumption) was performed at baseline, and after 1, 4, 6, 8, 12 and 14 months.Results: In the 15 knees treated, pain decreased (baseline vs. 14 months: VAS at rest, 3.7 +/- 1.7 vs. 1 +/- 0.7 [P < 0.000]; VAS activities, 6.2 +/- 1.7 vs. 2.6 +/- 1.3 [P < 0.000]) and function improved (baseline vs. 14 months: KOOS, 51.9 +/- 15.3 vs. 70.2 +/- 13.7 [P < 0.000]; LI, 10 +/- 3.8 vs. 5.4 +/- 2.4 [P < 0.000]) significantly.Conclusions: This schedule provides persistent positive results in terms of reduced pain and improved function, optimizing the protective properties of the hyaluronic acid used.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
